1. The Influence of Cigarette Smoking on the Medical Management of Angina

   • K. M. Fox
   • J. Deanfield
   • C. Wright

   Section 3: Angina and Arrhythmias 14 December 2012 Pages: 177 - 180

2. Short Term Evaluation of Atenolol in Hospitalised Patients with Chronic Ventricular Arrhythmias

   • J. Morganroth

   Section 3: Angina and Arrhythmias 14 December 2012 Pages: 181 - 185

3. Relevance of Physical Activity to the Antiarrhythmic Effects of β-Blockade on Supraventricular Tachycardias

   • V. Hombach
   • H. W. Höpp
   • H. H. Hilger

   Section 3: Angina and Arrhythmias 14 December 2012 Pages: 186 - 192

4. Atenolol in Angina

   • R. M. Boyle
   • C. L. Bray
   • J. M. Cruickshank

   Short Communication 14 December 2012 Pages: 193 - 194

5. Therapeutic Comparison between Atenolol and Nifedipine in Effort Angina

   • P. Gruppillo
   • R. Battaglia
   • A. Masoni

   Short Communication 14 December 2012 Pages: 194 - 195

6. Multiclinic Evaluation of the Antiarrhythmic Effect of Atenolol on Ventricular Arrhythmias

   • K. Yano
   • H. Hashiba
   • N. Ogawa

   Short Communication 14 December 2012 Pages: 195 - 196

7. Atenolol and Ventricular Ectopic Beats

   • H. A. Korst
   • J. W. Brandes
   • K. P. Littman

   Short Communication 14 December 2012 Pages: 196 - 196

8. The Pathophysiology of Toxaemia and Hypertension during Pregnancy

   • T. F. Ferris

   Section 4: Hypertension of Pregnancy 14 December 2012 Pages: 198 - 205

9. Atenolol in the Treatment of Hypertension of Pregnancy

   • H. Liedholm

   section 4: Hypertension of Pregnancy 14 December 2012 Pages: 206 - 211

10. Atenolol in the Management of Hypertension during Pregnancy

    • P. C. Rubin
    • L. Butters
    • J. L. Reid

    Section 4: Hypertension of Pregnancy 14 December 2012 Pages: 212 - 214

11. Treatment with Atenolol of Hypertension in Pregnancy

    • D. Dubois
    • J. Peticolas
    • A. Klepper

    Short Communication 14 December 2012 Pages: 215 - 216

12. Pharmacokinetics of Atenolol in Pregnancy and Lactation

    • K. J. Thorley

    Short Communication 14 December 2012 Pages: 216 - 217

13. Transplacental Passage and Breast Milk Accumulation of Atenolol in Humans

    • H. Liedholm

    Short Communication 14 December 2012 Pages: 217 - 218

14. Clinical Significance of Cardioselectivity State-of-the-Art

    • D. G. McDevitt

    Section 5: Cardioselectivity 14 December 2012 Pages: 219 - 226

15. Effect of β-Blocker Therapy on Airway Function

    • A. E. Tattersfield
    • R. N. Harrison

    Section 5: Cardioselectivity 14 December 2012 Pages: 227 - 231

16. β-Blockers in Asthma

    • D. S. Lawrence
    • J. N. Sahay
    • J. M. Cruickshank

    Section 5: Cardioselectivity 14 December 2012 Pages: 232 - 236

17. Effects of Atenolol and Propranolol on Glucose Metabolism and Hormonal Responses during Insulin-induced Hypoglycaemia in Normal Man

    • J. Lyngsøe
    • U. Birk Lauridsen
    • N. J. Christensen

    Section 5: Cardioselectivity 14 December 2012 Pages: 237 - 240

18. Muscle Fibre Composition, Short Term β₁- + β₂- and β₁-Blockade and Endurance Exercise Performance in Healthy Young Men

    • J. Karlsson

    Section 5: Cardioselectivity 14 December 2012 Pages: 241 - 246

19. β-Blockade and Coronary Arteries

    • M. J. Lewis
    • T. M. Griffith
    • A. H. Henderson

    Section 5: Cardioselectivity 14 December 2012 Pages: 247 - 249

20. Differences between Selective and Non-Selective β-Blockade

    • P. W. de Leeuw
    • G. A. W. van Soest
    • W. H. Birkenhäger

    Short Communication 14 December 2012 Pages: 250 - 250

21. Haemodynamics of Cardioselective β-Blockers without Partial Agonist Activity

    • H.-A. Wester

    Short Communication 14 December 2012 Pages: 250 - 250

22. The Effects of Atenolol in Patients with Severe Chronic Airflow Obstruction

    • W. H. Perks
    • R. S. E. Wilson
    • R. Steventon

    Short Communication 14 December 2012 Pages: 251 - 252

23. β-Adrenoceptor-linked Na/K ATPase

    • A. D. Struthers
    • J. L. Reid
    • J. C. Rodger

    Short Communication 14 December 2012 Pages: 253 - 253

24. Antihypertensive Effects and Kidney Function in Hypertensive Patients Treated with Atenolol and Oxprenolol

    • G. Bellini
    • G. Battilana
    • L. Campanacci

    Short Communication 14 December 2012 Pages: 253 - 255

25. Effects of Salbutamol, Indomethacin and Atenolol on Insulin Secretion

    • M. Stornello
    • G. Di Rao
    • L. Scapellato

    Short Communication 14 December 2012 Pages: 255 - 256

26. Response of Diabetics Treated with Atenolol or Propranolol to Insulin-induced Hypoglycaemia

    • J. R. Ryan
    • W. Lacorte
    • F. G. McMahon

    Short Communication 14 December 2012 Pages: 256 - 257

27. β-Blockade and Exercise Performance

    • J. Karlsson

    Short Communication 14 December 2012 Pages: 257 - 260

28. Oxygen Consumption and Lactate Metabolism during Exercise Following β-Adrenoceptor Blockade

    • P. Kaiser
    • P. Tesch
    • L. Kaijser

    Short Communication 14 December 2012 Pages: 260 - 261

29. β-Blockade and the Human Central Nervous System

    • P. Turner

    Section 6: β-Blockade and the Central Nervous System 14 December 2012 Pages: 262 - 264

30. The Effect of Atenolol on Reaction Times and Concentration

    • D. Harms
    • E. Pachale

    Section 6: β-Blockade and the Central Nervous System 14 December 2012 Pages: 265 - 267

31. β-Blocking Drugs and Sleep A Controlled Trial

    • T. A. Betts
    • C. Alford

    Section 6: β-Blockade and the Central Nervous System 14 December 2012 Pages: 268 - 272

32. β-Blockade in Subarachnoid Haemorrhage

    • G. Neil-Dwyer
    • P. Walter
    • C. Stratton

    Section 6: β-Blockade and the Central Nervous System 14 December 2012 Pages: 273 - 277

33. Atenolol in the Central Nervous System of Monkeys

    • B. Berzin
    • P. L. Asseman
    • Cl. Thery

    Short Communication 14 December 2012 Pages: 278 - 278

34. Atenolol Therapy in Hypertensive Patients Effects on Vigilance and Behaviour

    • G. K. Schenk
    • M. Anlauf

    Short Communication 14 December 2012 Pages: 278 - 278

35. Is There a Clinically Relevant Interaction Between Diazepam and Lipophilic β-Blocking Drugs?

    • T. A. Betts
    • A. Crowe
    • J. C. Petrie

    Short Communication 14 December 2012 Pages: 279 - 279

36. A Comparison of the Central Nervous System Side Effects Caused by Lipophilic and Hydrophilic β-Blockers

    • A. Westerlund

    Short Communication 14 December 2012 Pages: 280 - 281

37. Interventions During and After Acute Myocardial Infarction

    • Peter Sleight

    Section 7: Myocardial Infarction 14 December 2012 Pages: 282 - 294

38. Mechanisms of Myocardial Infarct Prevention with β-Adrenoceptor Blocking Drugs

    • B. N. C. Prichard

    Section 7: Myocardial Infarction 14 December 2012 Pages: 295 - 302

39. Reduction in Infarct Size, Arrhythmias, Chest Pain and Morbidity by Early Intravenous β-Blockade in Suspected Acute Myocardial Infarction

    • S. Yusuf
    • P. Rossi
    • P. Sleight

    Section 7: Myocardial Infarction 14 December 2012 Pages: 303 - 307

40. Principles and Practice of Treatment with β-Blockers in Myocardial Infarction

    • C. Wilhelmsson
    • A. Vedin

    Section 7: Myocardial Infarction 14 December 2012 Pages: 308 - 313

41. β-Blocker Heart Attack Trial

    • Curt D. Furberg

    Section 7: Myocardial Infarction 14 December 2012 Pages: 314 - 317

42. β-Blocker Withdrawal

    • A. J. J. Wood

    Section 8: Risks and Benefits of β-Blockers 14 December 2012 Pages: 318 - 321

43. A Comparison of the Effects of Atenolol and Metoprolol on Serum Lipoproteins

    • S. Rössner
    • L. Weiner

    Section 8: Risks and Benefits of β-Blockers 14 December 2012 Pages: 322 - 325

44. Clinical Evidence that β-Adrenoceptor Blockers Prevent More Cardiovascular Complications than Other Antihypertensive Drugs

    • D. G. Beevers
    • J. H. Johnston
    • P. Davies

    Section 8: Risks and Benefits of β-Blockers 14 December 2012 Pages: 326 - 330

45. How Safe are β-Blockers?

    • J. M. Cruickshank

    Section 8: Risks and Benefits of β-Blockers 14 December 2012 Pages: 331 - 340